{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T13:04:54Z","timestamp":1775567094382,"version":"3.50.1"},"reference-count":23,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Background\/Objectives: Cardiorenal syndrome type 2 (CRS-2) is characterized by progressive renal dysfunction caused by chronic heart failure (HF) and is associated with increased morbidity and mortality. However, the prognostic value of renal biomarkers in patients with CRS-2 hospitalized for decompensated HF remains unclear. Methods: This prospective observational cohort study included 200 consecutive patients hospitalized for decompensated HF in the Intensive Care Unit of the Clinic for Internal Medicine at the University Clinical Centre Tuzla between April and October 2025. CRS-2 was defined as chronic HF with chronic kidney disease persisting for \u22653 months before admission according to KDIGO criteria. Patients were followed for three months. The primary composite outcome was all-cause mortality or initiation of renal replacement therapy. Results: CRS-2 was identified in 130 patients (65.0%) and was associated with higher in-hospital mortality (32.3% vs. 11.4%, p = 0.002) and three-month mortality (44.6% vs. 21.4%, p = 0.002). Within the CRS-2 subgroup, patients who experienced the primary composite outcome had higher admission levels of cystatin C and urinary albumin-to-creatinine ratio (UACR) and lower estimated glomerular filtration rate (eGFR). ROC analysis demonstrated moderate discriminative ability of cystatin C (AUC 0.739) and UACR (AUC 0.733). In Cox regression analysis, cystatin C (HR 1.534, 95% CI 1.263\u20131.863, p &lt; 0.001) and UACR (HR 1.003, 95% CI 1.001\u20131.006, p = 0.001) were significantly associated with the primary composite outcome. Conclusions: Renal dysfunction markers, particularly cystatin C and albuminuria, are associated with early adverse outcomes in CRS-2 patients hospitalized for decompensated HF. Routine assessment of these biomarkers may provide additional prognostic information and support risk assessment in this high-risk population.<\/jats:p>","DOI":"10.3390\/medsci14020163","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T12:05:49Z","timestamp":1775563549000},"page":"163","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal Biomarkers and Albuminuria Predict Early Adverse Outcomes in Cardiorenal Syndrome Type 2"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4391-5226","authenticated-orcid":false,"given":"Minela","family":"Be\u0107irovi\u0107","sequence":"first","affiliation":[{"name":"Internal Medicine Clinic, University Clinical Center Tuzla, 75000 Tuzla, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4134-987X","authenticated-orcid":false,"given":"Emir","family":"Be\u0107irovi\u0107","sequence":"additional","affiliation":[{"name":"Internal Medicine Clinic, University Clinical Center Tuzla, 75000 Tuzla, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3988-8911","authenticated-orcid":false,"given":"Emir","family":"Begagi\u0107","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Cantonal Hospital Zenica, 72000 Zenica, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9478-3284","authenticated-orcid":false,"given":"Kenana","family":"Ljuca","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University Clinical Center Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7012-8064","authenticated-orcid":false,"given":"Amir","family":"Be\u0107irovi\u0107","sequence":"additional","affiliation":[{"name":"Internal Medicine Clinic, University Clinical Center Tuzla, 75000 Tuzla, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Mr\u0161i\u0107","sequence":"additional","affiliation":[{"name":"Internal Medicine Clinic, University Clinical Center Tuzla, 75000 Tuzla, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadina","family":"Ljuca","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Tuzla, 75000 Tuzla, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mugdim","family":"Bajri\u0107","sequence":"additional","affiliation":[{"name":"Clinic for Invasive Cardiology, University Clinical Center Tuzla, 75000 Tuzla, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1143-1941","authenticated-orcid":false,"given":"Farid","family":"Ljuca","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Medicine, University of Tuzla, 75000 Tuzla, Bosnia and Herzegovina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1111\/dom.16371","article-title":"The interplay between heart failure and chronic kidney disease","volume":"27","author":"Lala","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Alvi, A., Singamala, H., Gadde, S.S.V., and Javvaji, C.K. (2026). The intersection of heart failure and chronic kidney disease: Challenges in co-management. Cureus, 18.","DOI":"10.7759\/cureus.100993"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ajibowo, A.O., Okobi, O.E., Emore, E., Soladoye, E., Sike, C.G., Odoma, V.A., Bakare, I.O., Kolawole, O.A., Afolayan, A., and Okobi, E. (2023). Cardiorenal syndrome: A literature review. Cureus, 15.","DOI":"10.7759\/cureus.41252"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ye, L., Huang, X., and Xu, Y. (2025). Global trends and disparities in the burden of heart failure caused by chronic kidney disease: An analysis of the global burden of disease study 2021. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1567128"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gallo, G., Lanza, O., and Savoia, C. (2023). New insight in cardiorenal syndrome: From biomarkers to therapy. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065089"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Pradeep, U., Chiwhane, A., Acharya, S., Daiya, V., Kasat, P.R., Sachani, P., Mapari, S.A., and Bedi, G.N. (2024). A comprehensive review of advanced biomarkers for chronic kidney disease in older adults: Current insights and future directions. Cureus, 16.","DOI":"10.7759\/cureus.70413"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Visinescu, A.M., Rusu, E., Cosoreanu, A., and Radulian, G. (2024). Cystatin C\u2014A monitoring perspective of chronic kidney disease in patients with diabetes. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158135"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kumri\u0107, M., Borovac, J.A., Kurir, T.T., and Bo\u017ei\u0107, J. (2021). Clinical implications of uric acid in heart failure: A comprehensive review. Life, 11.","DOI":"10.3390\/life11010053"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Minneci, C., Zucchini, M., Gonzini, L., Marini, M., Gori, M., and De Maria, R. (2025). Italian Network on Heart Failure (IN-HF) Investigators. Serum uric acid, renal function and prognosis in patients with chronic heart failure and reduced ejection fraction: Insights from the Italian Network on Heart Failure. Int. J. Cardiol., 421.","DOI":"10.1016\/j.ijcard.2024.132906"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Li, J., Chu, Y., and Huang, M. (2025). Impact of renal dysfunction on prognosis in patients with severe heart failure: A retrospective cohort study. Medicine, 104.","DOI":"10.1097\/MD.0000000000044405"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Pliquett, R.U. (2022). Cardiorenal syndrome: An updated classification based on clinical hallmarks. J. Clin. Med., 11.","DOI":"10.3390\/jcm11102896"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Roman\u00f2, M. (2025). Heart Failure Syndromes: Different Definitions of Different Diseases\u2014Do We Need Separate Guidelines? A Narrative Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14145090"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.7861\/clinmed.2019-0422","article-title":"Heart failure and acute renal dysfunction in the cardiorenal syndrome","volume":"20","author":"Chahal","year":"2020","journal-title":"Clin. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Nagy, E., Abdelfattah, A.H., Sayed-Ahmed, N., and Ahmed, S. (2025). Cystatin C as a predictor of renal recovery and in-hospital mortality in patients with acute kidney injury and liver cirrhosis. BMC Nephrol., 26.","DOI":"10.1186\/s12882-025-04341-7"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40620-020-00842-w","article-title":"Renal dysfunction in cardiovascular diseases and its consequences","volume":"34","author":"Deferrari","year":"2021","journal-title":"J. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Pagano, M., Anselmo, A., Micali, G., Giamb\u00f2, F.M., Speciale, F., Costanzo, D., D\u2019Aleo, P., Duca, A., Bramanti, A., and Garofano, M. (2025). Comparison of cardiorenal syndrome and heart failure: A preliminary study of clinical, cognitive, and emotional aspects. NeuroSci, 6.","DOI":"10.3390\/neurosci6040129"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Alam, M., Mahapatra, H.S., Kaur, R., Pursnani, L.K., Balakrishnan, M., Binoy, R., Thakker, T., Suman, B., and Jha, A. (2025). Short-term renal replacement therapy outcomes of critically ill patients with acute kidney injury and acute-on-chronic kidney disease. Cureus, 17.","DOI":"10.7759\/cureus.78183"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Wojtaszek, E., Kwiatkowska-Stawiarczyk, M., Sobieszcza\u0144ska-Ma\u0142ek, M., G\u0142ogowski, T., Kaszy\u0144ska, A., Markowski, M., Ma\u0142yszko, S., and Ma\u0142yszko, J. (2025). Heart failure\u2014Focus on kidney replacement therapy: Why, when, and how?. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26062456"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Li, J., Guan, S., Zou, Z., Yang, L., Qian, B., Shen, L., and Li, Y. (2025). Evaluation of cystatin C and microalbuminuria as predictive markers for hypertension-related renal complications. Hereditas, 162.","DOI":"10.1186\/s41065-025-00557-7"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Barzilay, J.I., Farag, Y.M.K., and Durthaler, J. (2024). Albuminuria: An underappreciated risk factor for cardiovascular disease. J. Am. Heart Assoc., 13.","DOI":"10.1161\/JAHA.123.030131"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jceh.2020.12.005","article-title":"Admission serum urea is a better predictor of mortality than creatinine in patients with acute-on-chronic liver failure and acute kidney injury","volume":"11","author":"Khatua","year":"2021","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/ndt\/gfad131","article-title":"The urine-to-plasma urea concentration ratio is associated with eGFR and eGFR decline over time in a population cohort","volume":"39","author":"Petrovic","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Caturano, A., Galiero, R., Rocco, M., Tagliaferri, G., Piacevole, A., Nilo, D., Di Lorenzo, G., Sardu, C., Russo, V., and Vetrano, E. (2024). The dual burden: Exploring cardiovascular complications in chronic kidney disease. Biomolecules, 14.","DOI":"10.3390\/biom14111393"}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/2\/163\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T12:26:56Z","timestamp":1775564816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/2\/163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["medsci14020163"],"URL":"https:\/\/doi.org\/10.3390\/medsci14020163","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]}}}